查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球蟲媒病毒測試市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按測試類型、按最終用戶、按地區
市場調查報告書
商品編碼
1394139

全球蟲媒病毒測試市場 - 全球產業分析、規模、份額、成長、趨勢、預測 (2031) - 按測試類型、按最終用戶、按地區

Arbovirus Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
出版日期: | 出版商: Fairfield Market Research | 英文 172 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

預計 2024 年至 2031 年預測期內，全球蟲媒病毒檢測市場規模將顯著成長。 蟲媒病毒主要透過蚊子和蜱蟲等受感染的節肢動物傳播給人類，由於其對公共衛生的影響而受到越來越多的關注。

全球蟲媒病毒檢測市場的成長取決於多種因素，例如蟲媒病毒的快速出現、日益嚴峻的公共衛生挑戰以及政府綜合措施的實施。 這些驅動因素共同促進了蟲媒病毒檢測市場在全球範圍內的成長和擴張。

公共衛生實驗室處於世界各地蟲媒病毒檢測的最前線。 就價值而言，公共衛生實驗室部分是最大的，預計在整個評估期間將保持這一地位。 其顯著的收入創造為蟲媒病毒檢測市場的整體成長做出了重大貢獻。

最終用戶類別中的醫院細分市場預計將顯著成長，並且是價值最高的細分市場之一。 儘管成長率相對溫和，但預計會大幅擴張，反映出醫院在蟲媒病毒檢測方面日益重要。

本報告考察了全球蟲媒病毒檢測市場，並提供了市場概述，包括按檢測類型、最終用戶、地區劃分的趨勢以及進入市場的公司的競爭趨勢。

目錄

第 1 章執行摘要

第二章市場概述

  • 市場定義與細分
  • 市場動態
  • 價值鏈分析
  • 波特五力分析
  • 新冠肺炎 (COVID-19) 影響分析
  • 烏克蘭和俄羅斯之間衝突的影響
  • 經濟概況
  • 杵分析

第 3 章全球蟲媒病毒檢測市場前景，2018-2031

  • 2018-2031 年全球蟲媒病毒檢測市場展望（按檢測類型、價值（十億美元））
  • 2018-2031 年全球蟲媒病毒檢測市場前景（按最終用戶劃分）價值（十億美元）
  • 2018-2031 年全球蟲媒病毒檢測市場前景（按地區、價值（十億美元））

第 4 章北美蟲媒病毒檢測市場前景，2018-2031

第五章歐洲蟲媒病毒檢測市場前景，2018-2031

第 6 章亞太地區蟲媒病毒檢測市場展望，2018-2031 年

第 7 章拉丁美洲蟲媒病毒檢測市場展望，2018-2031 年

第 8 章中東與非洲蟲媒病毒檢測市場前景，2018-2031 年

第九章競爭態勢

  • 製造商和最終用戶的熱圖
  • 2023 年公司市佔率分析
  • 競爭力儀表板
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
    • Diamedix Corporation
    • NovaTec Immundiagnostica GmbH
    • Euroimmun AG
    • Focus Diagnostics (Member of DiaSorin Group)
    • Standard Diagnostics, Inc.
    • IBL International (A Member of the Tecan Group) Alere

第 10 章附錄

簡介目錄

The global market for arbovirus testing is poised for substantial growth over the forecast period from 2024 to 2031, according to a comprehensive market study. Arboviruses, which are primarily transmitted to humans through infected arthropods like mosquitoes and ticks, have gained increasing attention due to their public health impact. The research report delves into the latest trends, opportunities, drivers, and challenges influencing the market, offering valuable insights for industry stakeholders.

Expanding Horizons in Arbovirus Testing

The scope of this research encompasses a thorough analysis of end-user preferences, competitive dynamics, regional outlook, and various test types within arbovirus testing. Asia-Pacific and Middle East & Africa emerge as promising markets, driven by their substantial populations at risk of arbovirus infections and high arbovirus prevalence. Manufacturers are focused on advancing diagnostic techniques, extending their applicability beyond a few infections, thereby fueling market growth.

Key Drivers of Growth

The growth of the global arbovirus testing market hinges on several factors, including the rapid emergence of arboviruses, increasing public health challenges, and the implementation of integrated government initiatives. These drivers collectively contribute to the growth and expansion of the arbovirus testing market on a global scale.

Dominance of Public Health Laboratories

Public health laboratories have been at the forefront of arbovirus testing efforts worldwide. In terms of value, the public health laboratory segment is the largest and is expected to maintain this position throughout the assessment period. Its remarkable revenue generation significantly contributes to the overall growth of the arbovirus testing market.

Hospitals on the Rise

The hospital segment within the end-user category is anticipated to experience substantial growth, positioning itself as one of the top segments in terms of value. Despite a comparatively slower growth rate, it is projected to expand noticeably, reflecting the increasing importance of hospitals in arbovirus testing.

Market Segmentation

The market segmentation for the arbovirus testing industry includes test types, end users, and regions:

By Test Type:

  • 1. ELISA-Based Tests
  • 2. RT-PCR Based Tests

By End User:

  • 1. Hospitals
  • 2. Public Health Laboratories
  • 3. Diagnostic Centers
  • 4. Others

By Region:

  • 1. North America
  • 2. Latin America
  • 3. Europe
  • 4. Asia Pacific (APAC)
  • 5. Middle East and Africa (MEA)

The global arbovirus testing market is set to witness significant growth and innovation in the coming years, with a range of opportunities and challenges for businesses in this sector. Stakeholders, including manufacturers, healthcare providers, and public health agencies, are gearing up to address the growing threat of arbovirus infections and contribute to the advancement of diagnostic capabilities.

Table of Contents

1. Executive Summary

  • 1.1. Global Arbovirus Testing Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Arbovirus Testing Market Outlook, 2018 - 2031

  • 3.1. Global Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. ELISA-Based Tests
      • 3.1.1.2. RT-PCR Based Tests
  • 3.2. Global Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Hospitals
      • 3.2.1.2. Public Health Laboratory
      • 3.2.1.3. Diagnostic Centers
      • 3.2.1.4. Others
  • 3.3. Global Arbovirus Testing Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. North America
      • 3.3.1.2. Europe
      • 3.3.1.3. Asia Pacific
      • 3.3.1.4. Latin America
      • 3.3.1.5. Middle East & Africa

4. North America Arbovirus Testing Market Outlook, 2018 - 2031

  • 4.1. North America Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. ELISA-Based Tests
      • 4.1.1.2. RT-PCR Based Tests
  • 4.2. North America Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hospitals
      • 4.2.1.2. Public Health Laboratory
      • 4.2.1.3. Diagnostic Centers
      • 4.2.1.4. Others
    • 4.2.2. BPS Analysis/Market Attractiveness Analysis
  • 4.3. North America Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. U.S. Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.2. U.S. Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 4.3.1.3. Canada Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 4.3.1.4. Canada Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 4.3.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Arbovirus Testing Market Outlook, 2018 - 2031

  • 5.1. Europe Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. ELISA-Based Tests
      • 5.1.1.2. RT-PCR Based Tests
  • 5.2. Europe Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hospitals
      • 5.2.1.2. Public Health Laboratory
      • 5.2.1.3. Diagnostic Centers
      • 5.2.1.4. Others
    • 5.2.2. BPS Analysis/Market Attractiveness Analysis
  • 5.3. Europe Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Germany Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.2. Germany Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.3. U.K. Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.4. U.K. Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.5. France Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.6. France Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.7. Italy Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.8. Italy Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.9. Turkey Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.10. Turkey Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.11. Russia Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.12. Russia Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 5.3.1.13. Rest of Europe Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 5.3.1.14. Rest of Europe Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Arbovirus Testing Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. ELISA-Based Tests
      • 6.1.1.2. RT-PCR Based Tests
  • 6.2. Asia Pacific Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hospitals
      • 6.2.1.2. Public Health Laboratory
      • 6.2.1.3. Diagnostic Centers
      • 6.2.1.4. Others
    • 6.2.2. Others BPS Analysis/Market Attractiveness Analysis
  • 6.3. Asia Pacific Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. China Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.2. China Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.3. Japan Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.4. Japan Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.5. South Korea Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.6. South Korea Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.7. India Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.8. India Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.9. Southeast Asia Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.10. Southeast Asia Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 6.3.1.11. Rest of Asia Pacific Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 6.3.1.12. Rest of Asia Pacific Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Arbovirus Testing Market Outlook, 2018 - 2031

  • 7.1. Latin America Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. ELISA-Based Tests
      • 7.1.1.2. RT-PCR Based Tests
  • 7.2. Latin America Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Hospitals
      • 7.2.1.2. Public Health Laboratory
      • 7.2.1.3. Diagnostic Centers
      • 7.2.1.4. Others
    • 7.2.2. BPS Analysis/Market Attractiveness Analysis
  • 7.3. Latin America Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Brazil Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.2. Brazil Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.3. Mexico Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.4. Mexico Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.5. Argentina Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.6. Argentina Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 7.3.1.7. Rest of Latin America Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 7.3.1.8. Rest of Latin America Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Arbovirus Testing Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Arbovirus Testing Market Outlook, by Test Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. ELISA-Based Tests
      • 8.1.1.2. RT-PCR Based Tests
  • 8.2. Middle East & Africa Arbovirus Testing Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hospitals
      • 8.2.1.2. Public Health Laboratory
      • 8.2.1.3. Diagnostic Centers
      • 8.2.1.4. Others
    • 8.2.2. BPS Analysis/Market Attractiveness Analysis
  • 8.3. Middle East & Africa Arbovirus Testing Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. GCC Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.2. GCC Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.3. South Africa Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.4. South Africa Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.5. Egypt Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.6. Egypt Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.7. Nigeria Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.8. Nigeria Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
      • 8.3.1.9. Rest of Middle East & Africa Arbovirus Testing Market by Test Type, Value (US$ Bn), 2018 - 2031
      • 8.3.1.10. Rest of Middle East & Africa Arbovirus Testing Market by End User, Value (US$ Bn), 2018 - 2031
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Manufacturer vs by End User Heatmap
  • 9.2. Company Market Share Analysis, 2023
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Thermo Fisher Scientific, Inc.
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Development
    • 9.4.2. Diamedix Corporation
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Development
    • 9.4.3. NovaTec Immundiagnostica GmbH
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Development
    • 9.4.4. Euroimmun AG
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Development
    • 9.4.5. Focus Diagnostics (Member of DiaSorin Group)
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Development
    • 9.4.6. Standard Diagnostics, Inc.
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Development
    • 9.4.7. IBL International (A Member of the Tecan Group)
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Development
    • 9.4.8. Alere
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations